CABOZANTINIB HAS ACTIVITY IN CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2013年 / 3卷 / 01期
关键词：
D O I：
10.1158/2159-8290.CD-RW2012-216
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] Current role of cabozantinib in metastatic castration-resistant prostate cancer
    Fay, Andre P.
    Albiges, Laurence
    Bellmunt, Joaquim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (02) : 151 - 156
  • [2] Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer
    Madan, Ravi A.
    Karzai, Fatima H.
    Al Harthy, Munjid
    Petrylak, Daniel P.
    Kim, Joseph W.
    Arlen, Philip M.
    Rosner, Inger
    Theoret, Marc R.
    Cordes, Lisa
    Bilusic, Marijo
    Peer, Cody J.
    Dawson, Nancy A.
    Couvillon, Anna
    Hankin, Amy
    Williams, Moniquea
    Chun, Guin
    Owens, Helen
    Marte, Jennifer L.
    Lee, Min-Jung
    Tomita, Yusuke
    Yuno, Akira
    Trepel, Jane B.
    Lee, Sunmin
    Steinberg, Seth M.
    Gulley, James L.
    Figg, William D.
    Dahut, William L.
    BJU INTERNATIONAL, 2021, 127 (04) : 435 - 444
  • [3] Galeterone activity in castration-resistant prostate cancer
    Yaqub, Farhat
    LANCET ONCOLOGY, 2015, 16 (01): : E10 - E10
  • [4] Abiraterone has benefits for metastatic castration-resistant prostate cancer
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (01) : 8 - 8
  • [5] Prostate cancer: MDV3100 has antitumor activity in castration-resistant disease
    Payton S.
    Nature Reviews Urology, 2010, 7 (6) : 300 - 300
  • [6] DIETHYLSTILBESTROL IN CASTRATION-RESISTANT PROSTATE CANCER OESTROGENS IN CASTRATION-RESISTANT PROSTATE CANCER: BACK TO THE FUTURE?
    Sartor, Oliver
    BJU INTERNATIONAL, 2012, 110 (11B) : E736 - E736
  • [7] A phase 2 study of cabozantinib and nivolumab in metastatic castration-resistant prostate cancer (CANOPY)
    Chen, Yu-Wei
    Liu, Lin
    Pu, Minya
    Pena, Samuel
    Qin, Qian
    Zhang, Tian
    Emamekhoo, Hamid
    Lang, Joshua Michael
    Patnaik, Akash
    McKkay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : TPS239 - TPS239
  • [8] Immunotherapy for castration-resistant prostate cancer: has its time arrived?
    Slovin, Susan F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (05) : 481 - 487
  • [9] Darolutamide For Castration-Resistant Prostate Cancer
    Bastos, Diogo A.
    Antonarakis, Emmanuel S.
    ONCOTARGETS AND THERAPY, 2019, 12 : 8769 - 8777
  • [10] Immunotherapy for Castration-Resistant Prostate Cancer
    Sonpavde, Guru
    Kantoff, Philip W.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 465 - +
12345